Number | 48 |
Background information | |
 Gender (male, n (%) | 36 (75 %) |
 Age (years), mean ± SD (range) | 64.0 ± 7.3 (41.4–76,7) |
 Body Mass Index (kg/m2), mean ± SD (range) | 29.6 ± 4.3 (21.7–39.7) |
 T2DM duration (years), mean ± SD (range) | 14.6 ± 6.4 (6.8–37.7) |
Medical history and medications | |
 History of smoking, n (%) | 19 (39.6 %) |
 Family history of premature CAD (1st degree relative), n (%) | 24 (50 %) |
 Any medication for hypertension, n (%) | 36 (75 %) |
 Any lipidlowering medication, n (%) | 38 (79 %) |
 Any blood glucose lowering medication, n (%) | 46 (96 %) |
-Any use of insulin, n (%) | 9 (18.7Â %) |
Laboratory and clinically assessment | |
 HbA1c (%), mean ± SD | 7,4 ± 1.1 |
 Serum creatinine (μmol/L), mean ± SD (range) | 71.4 ± 16.7 (42–117) |
 Total cholesterol (mmol/L), mean ± SD | 4.3 ± 1.0 |
 LDL cholesterol (mmol/L), mean ± SD | 2.4 ± 0.8 |
 HDL cholesterol (mmol/L), mean ± SD | 1.4 ± 0.4 |
 Triglycerides (mmol/L), mean ± SD | 1.3 ± 0.5 |
 Systolic blood pressure (mmHg), mean ± SD | 138 ± 17 |
 Diastolic blood pressure (mmHg), mean ± SD | 79 ± 8 |
 Heart rate (bpm), mean ± SD | 73 ± 13 |
Exercise ECG | Â |
- Positive, n (%) - Inconclusive, n (%) - Negative, n (%) | 4 (8.3Â %) 11 (22.9Â %) 33 (68.8Â %) |